HIV mutation literature information.


  HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.
 PMID: 26717411       2015       PloS one
Result: K70R, L74V/I, Y115F, M184I, and T215Y/F were the most common major non-tier 1 DRMs associated with ADR on a first-line NRTI/NNRTI-containing regimen and with TDR.
Result: M184I, K65R,
Figure: Major NRTI-associated DRMs (HIVDB score >=30) included K65R, D67 deletion, T69 insertion, K70R, L74V/I, Y115F, Q151M, M184I/V, and T215F/Y.


  Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.
 PMID: 24444369       2014       AIDS research and therapy
Table: Y115F


  Genotypic resistance profiles of HIV-2-treated patients in West Africa.
 PMID: 24583671       2014       AIDS (London, England)
Method: In this study, HIV-2 resistance mutations were identified using the list generated by the 'Collaborative HIV and Anti-HIV Drug Resistance Network', leading to the following mutations in reverse transcriptase - K65R, D67G/N, N69S/T, K70N/R, L74V, V111I, Y115F, M184I/V, Q151M, S215A/C/F/L/Y, K223R; and in protease - V47A, G48V, I50V, I54L/M,


  Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.
 PMID: 24633208       2014       The Journal of antimicrobial chemotherapy
Abstract: In multivariate regression models, K65R, Y115F and the presence of thymidine analogue-associated mutations were associated with increased susceptibility to etravirine in the cABC arm.
Result: However, in the case of etravirine, K65R, Y115F and the presence of TAMs were associated with increased susceptibility, whilst N348I was associated with decreased susceptibility.
Table: Y115F


  Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.
 PMID: 24760888       2014       Journal of virology
Abstract: We show here that four mutations (Y115F, M184V, M184I, and Q151M) in the dNTP-binding pocket of RT that had relatively small effects on the overall HIV-1 mutation rate (less than 3-fold compared to the wild type) significantly increased mutations at some specific positions in the lacZalpha reporter gene.


  A uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in Russian subtype A HIV-1 viruses.
 PMID: 25259833       2014       AIDS (London, England)
Result: One or more of the non-TAMs, K65R/N, L74V/I, and Y115F were present in 1.4% (n = 3), 26% (n = 16), and 9.2% (n = 8) of patients receiving thymidine-analog, nonthymidine-analog, and both thymidine-analog and nonthymidine-analog regimens.


  Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy.
 PMID: 23079810       2013       AIDS (London, England)
Result: Patients on TDF based regimens were significantly more likely to have thymidine-sparing mutations (K65R (57%), M184I (30%), Y115F (13%)) as compared to AZT and d4T based regimens (p<=0.02).
Discussion: M184I (7/23) and Y115F (3/23), are relatively uncommon mutations but occurred more often for those on tenofovir.
Discussion: The M184I may eventually switch to M184V and Y115F may be increasing for those on tenofovir, but the small numbers limit our inferences.


  HIV-2 antiviral potency and selection of drug resistance mutations by the integrase strand transfer inhibitor elvitegravir and NRTIs emtricitabine and tenofovir in vitro.
 PMID: 23187937       2013       Journal of acquired immune deficiency syndromes (1999)
Abstract: In resistance selections, EVG selected E92G/Q and S147N in integrase, FTC selected M184V/I in RT, and TFV selected K65R and Y115F in RT.
Abstract: The RT K65R SDM virus had 2.2- and 9.1-fold reduced susceptibilities to TFV and FTC, respectively, and the addition of Y115F to K65R further decreased susceptibility to both drugs.


  Description of HIV-1 group M molecular epidemiology and drug resistance prevalence in Equatorial Guinea from migrants in Spain.
 PMID: 23717585       2013       PloS one
Table: Y115F


  Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.
 PMID: 23840622       2013       PloS one
Abstract: Compared with 720 recipients of a d4T or AZT-containing first-line regimen, the 153 recipients of a TDF-containing first-line regimen were more likely to have the RT mutations K65R (46% vs 4.0%; p<0.001
Discussion: Among patients with virological failure on a first-line dual NRTI plus NNRTI regimen, a higher proportion of those who received TDF and/or ABC had the non-TAMs K65R, K70EQG, L74VI, and Y115F compared with those receiving d4T or AZT.
Discussion: As in our study, M184V, K65R, and Y115F were the most common major NRTI mutations.



Browser Board

 Co-occurred Entities




   Filtrator